[1]Marwick TH. The viable myocardium: epidemiology,detection, and clinical implications[J]. The Lancet, 1998, 351(9105): 815-819. [2]Braunwald E and Kloner R. The stunned myocardium:prolonged, postischemic ventricular dysfunction[J]. Circulation, 1982, 66(6): 1146-1149. [3]Rahimtoola SH. The hibernating myocardium[J].American heart journal, 1989, 117(1): 211-221. [4]Fishbein MC, Y-Rit J, Lando U, et al. Therelationship of vascular injury and myocardial hemorrhage to necrosis afterreperfusion[J]. Circulation, 1980, 62(6): 1274-1279. [5]Heusch G and Schulz R. Characterization ofhibernating and stunned myocardium[J]. European heart journal, 1997, 18(supplD): 102-110. [7]刘霞. 急性心肌梗死心电图的诊断名称与标准[J]. 临床心电学杂志, 2011(03): 164-166. [6]Cianfrocca C, Pelliccia F, Pasceri V, et al. Strainrate analysis and levosimendan improve detection of myocardial viability bydobutamine echocardiography in patients with post-infarction left ventriculardysfunction: a pilot study[J]. Journal of the American Society of Echocardiography,2008, 21(9): 1068-1074. [8]Lauerma K, Niemi P, H nninen H, et al.Multimodality MR Imaging Assessment of Myocardial Viability: Combination ofFirst-Pass and Late Contrast Enhancement to Wall Motion Dynamics and Comparisonwith FDG PET-Initial Experience1[J]. Radiology, 2000, 217(3): 729-736. [9]Marysael T, Bauwens M, Ni Y, et al. Pretargeting ofnecrotic tumors with biotinylated hypericin using 123I-labeled avidin:evaluation of a two-step strategy[J]. Invest New Drugs, 2012, 30(6): 2132-140. [10]Ni Y, Huyghe D, Verbeke K, et al. Firstpreclinical evaluation of mono-[123I] iodohypericin as a necrosis-avidtracer agent[J]. European journal of nuclear medicine and molecular imaging,2006, 33(5): 595-601. [11]Fonge H, Vunckx K, Wang H, et al. Non-invasivedetection and quantification of acute myocardial infarction in rabbits usingMONO-[123I] iodohypericin SPECT[J]. European heart journal, 2008,29(2): 260-269. [12]Bormans G, Huyghe D,Christiaen A, et al. Pr-eparation, analysis and biodistribution in mice ofiodine-123 labelled derivatives of hypericin[J]. Journal of Labelled Compoundsand Radiopharmaceuticals, 2004, 47(3): 191-198. |